By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bavarian Nordic A/S 

Vesterbrogade 149

Copenhagen    DK-1620  Denmark
Phone: 45-3326-8383 Fax: 45-3326-8380


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





Company News
Bavarian Nordic (BAVA.CO) Announces First Patient Treated In A Phase 1 Study Of MVA-BN® Brachyury In Advanced Cancer 7/24/2014 9:13:08 AM
Total Number Of Voting Rights And Share Capital In Bavarian Nordic (BAVA.CO) 6/2/2014 9:36:46 AM
Bavarian Nordic (BAVA.CO) Taps Paul Chaplin, Ph.D. For President & CEO Post 5/29/2014 10:37:39 AM
Report Of Transactions Of Shares And Related Securities Of Bavarian Nordic (BAVA.CO) By Persons Holding Managerial Responsibilities And/Or Persons/Companies Closely Associated With Such 5/29/2014 9:13:20 AM
Bavarian Nordic (BAVA.CO) Issues New Shares In Connection With Exercise Of Warrants 5/27/2014 9:01:52 AM
Bavarian Nordic (BAVA.CO) Announces First Patient Treated In A Phase 2 Study Evaluating Its Immunotherapy Candidate CV-301 In Bladder Cancer 4/28/2014 8:58:18 AM
Bavarian Nordic (BAVA.CO) Welcomes Gerard Van Odijk As New Chairman Of The Board 4/25/2014 9:24:58 AM
Bavarian Nordic (BAVA.CO) - Report On The Results Of The Annual General Meeting, Held 24 April 2014 4/25/2014 8:41:40 AM
Bavarian Nordic (BAVA.CO) Announces Execution Of Option On Freeze-Dried IMVAMUNE 4/22/2014 9:03:31 AM
Bavarian Nordic (BAVA.CO) Presents Combination Immunotherapy Data Of PROSTVAC Plus Ipilimumab At The American Association for Cancer Research Annual Meeting 2014 4/7/2014 9:02:00 AM
12345678910...
//-->